Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF
Open Access
- 15 July 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (2) , 624-631
- https://doi.org/10.1182/blood-2007-01-065714
Abstract
Vascular endothelial growth factor (VEGF), a major factor in tumor-host interactions, plays a critical role in the aberrant hematopoiesis observed inKeywords
This publication has 56 references indexed in Scilit:
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- The biology of VEGF and its receptorsNature Medicine, 2003
- Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptorBlood, 2003
- Clinical significance of the determination of angiogenic factorsEuropean Journal Of Cancer, 1996
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological ActivitiesJournal of Biological Chemistry, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- An intermediate cell in thymocyte differentiation that expresses CD8 but not CD4 antigen.The Journal of Experimental Medicine, 1987